Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Masini

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
La Radiologia Medica|September 8, 2016
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO)Paola Franzone, Alba Fiorentino, Salvina Barra, et al.
The Plant Cell|December 20, 2011
GLYCOALKALOID METABOLISM1 is required for steroidal alkaloid glycosylation and prevention of phytotoxicity in tomatoMaxim Itkin, Ilana Rogachev, Noam Alkan, et al.
Plos One|February 8, 2014
Functional analysis of the tomato immune receptor Ve1 through domain swaps with its non-functional homolog Ve2Emilie F Fradin, Zhao Zhang, Hanna Rovenich, et al.
Home Health Care Services Quarterly|October 15, 2021
Effects of activity tracker-based counselling and live-web exercise on breast cancer survivors' sleep and waking time during Italy's COVID-19 lockdownAndrea Di Blasio, Teresa Morano, Federica Lancia, et al.
Journal of Functional Morphology and Kinesiology|July 2, 2021
Effects of Activity Tracker-Based Counselling and Live-Web Exercise on Breast Cancer Survivors during Italy COVID-19 LockdownAndrea Di Blasio, Teresa Morano, Federica Lancia, et al.
Journal of Neuro-Oncology|May 5, 2019
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trialSara Pedretti, Laura Masini, Enrico Turco, et al.
La Radiologia Medica|September 8, 2017
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO)Silvia Scoccianti, Marco Krengli, Livia Marrazzo, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 19, 2020
AKR1C3 is a biomarker and druggable target for oropharyngeal tumorsCaterina Peraldo-Neia, Paola Ostano, Maurizia Mello-Grand, et al.
Neuro-Oncology|April 28, 2012
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology)Silvia Scoccianti, Stefano Maria Magrini, Umberto Ricardi, et al.
Journal of Neuro-Oncology|December 6, 2018
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)Pierina Navarria, Giuseppe Minniti, Elena Clerici, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
La Radiologia Medica|September 8, 2016
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO)Paola Franzone, Alba Fiorentino, Salvina Barra, et al.
The Plant Cell|December 20, 2011
GLYCOALKALOID METABOLISM1 is required for steroidal alkaloid glycosylation and prevention of phytotoxicity in tomatoMaxim Itkin, Ilana Rogachev, Noam Alkan, et al.
Plos One|February 8, 2014
Functional analysis of the tomato immune receptor Ve1 through domain swaps with its non-functional homolog Ve2Emilie F Fradin, Zhao Zhang, Hanna Rovenich, et al.
Home Health Care Services Quarterly|October 15, 2021
Effects of activity tracker-based counselling and live-web exercise on breast cancer survivors' sleep and waking time during Italy's COVID-19 lockdownAndrea Di Blasio, Teresa Morano, Federica Lancia, et al.
Journal of Functional Morphology and Kinesiology|July 2, 2021
Effects of Activity Tracker-Based Counselling and Live-Web Exercise on Breast Cancer Survivors during Italy COVID-19 LockdownAndrea Di Blasio, Teresa Morano, Federica Lancia, et al.
Journal of Neuro-Oncology|May 5, 2019
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trialSara Pedretti, Laura Masini, Enrico Turco, et al.
La Radiologia Medica|September 8, 2017
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO)Silvia Scoccianti, Marco Krengli, Livia Marrazzo, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 19, 2020
AKR1C3 is a biomarker and druggable target for oropharyngeal tumorsCaterina Peraldo-Neia, Paola Ostano, Maurizia Mello-Grand, et al.
Neuro-Oncology|April 28, 2012
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology)Silvia Scoccianti, Stefano Maria Magrini, Umberto Ricardi, et al.
Journal of Neuro-Oncology|December 6, 2018
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)Pierina Navarria, Giuseppe Minniti, Elena Clerici, et al.
Pageof 6